Jump to content

Ublituximab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DePiep (talk | contribs) at 09:58, 20 November 2015 (Identifier not assigned: use =none (CAS RN, ChemSpider, ATC) (via AWB script)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Ublituximab
Monoclonal antibody
TypeWhole antibody
SourceChimeric (mouse/human)
TargetCD20
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
 ☒NcheckY (what is this?)  (verify)

Ublituximab is an immunomodulator. It binds to CD20.[1]

References

  1. ^ World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 104" (PDF). WHO Drug Information. 24 (4).